Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 10,625 shares at $40.10 ($435K) on 2015-03-02, disclosed to the SEC on 2015-03-03.
Scheduled sale ($435k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.10 | 6,561 | $263K | 60.5% |
| 2 | $41.58 | 1,314 | $55K | 12.6% |
| 3 | $42.49 | 2,150 | $91K | 21.0% |
| 4 | $43.10 | 600 | $26K | 5.9% |
| Total | $40.94 avg | 10,625 | $435K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |